The TXN system suppresses ferroptosis through multiple mechanisms: by supplying reducing equivalents to PRDXs, facilitating cystine-to-cysteine reduction to support GSH synthesis, and acting as an independent ferroptosis suppressor (Fig
These include: Neurological symptoms : tingling or numbness in hands and feet (peripheral neuropathy), difficulty walking or balance problems, memory difficulties, or mood changes including depression Haematological signs : persistent fatigue, weakness, pale or jaundiced skin, or shortness of breath Glossitis : a sore, red, smooth tongue Cognitive symptoms : difficulty concentrating, confusion, or "brain fog" Seek urgent medical attention if you experience rapidly worsening neurological symptoms, significant difficulty walking, severe paraesthesia, or marked cognitive decline, as these may require immediate assessment
Beyond patient-level safety, production and disposal introduce concerns about occupational and environmental exposure
For the best outcomes, pair B12/MIC injections with a healthy diet and consistent exercise routine